![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: UBP1 |
Gene summary for UBP1 |
![]() |
Gene information | Species | Human | Gene symbol | UBP1 | Gene ID | 7342 |
Gene name | upstream binding protein 1 | |
Gene Alias | LBP-1B | |
Cytomap | 3p22.3 | |
Gene Type | protein-coding | GO ID | GO:0001525 | UniProtAcc | A0A024R2J0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7342 | UBP1 | LZE4T | Human | Esophagus | ESCC | 5.56e-07 | 3.64e-02 | 0.0811 |
7342 | UBP1 | LZE7T | Human | Esophagus | ESCC | 1.01e-02 | 7.74e-02 | 0.0667 |
7342 | UBP1 | LZE20T | Human | Esophagus | ESCC | 2.42e-03 | -5.34e-03 | 0.0662 |
7342 | UBP1 | LZE24T | Human | Esophagus | ESCC | 3.00e-07 | 8.30e-02 | 0.0596 |
7342 | UBP1 | P2T-E | Human | Esophagus | ESCC | 6.28e-12 | -1.00e-02 | 0.1177 |
7342 | UBP1 | P4T-E | Human | Esophagus | ESCC | 5.23e-06 | 1.49e-01 | 0.1323 |
7342 | UBP1 | P5T-E | Human | Esophagus | ESCC | 2.45e-10 | 1.34e-02 | 0.1327 |
7342 | UBP1 | P8T-E | Human | Esophagus | ESCC | 2.85e-10 | 8.14e-02 | 0.0889 |
7342 | UBP1 | P9T-E | Human | Esophagus | ESCC | 2.53e-09 | 5.94e-02 | 0.1131 |
7342 | UBP1 | P10T-E | Human | Esophagus | ESCC | 1.60e-07 | 9.92e-02 | 0.116 |
7342 | UBP1 | P11T-E | Human | Esophagus | ESCC | 2.45e-09 | 1.58e-01 | 0.1426 |
7342 | UBP1 | P12T-E | Human | Esophagus | ESCC | 6.09e-14 | 2.86e-02 | 0.1122 |
7342 | UBP1 | P15T-E | Human | Esophagus | ESCC | 2.12e-10 | 1.64e-01 | 0.1149 |
7342 | UBP1 | P20T-E | Human | Esophagus | ESCC | 2.18e-06 | -2.37e-03 | 0.1124 |
7342 | UBP1 | P21T-E | Human | Esophagus | ESCC | 1.60e-11 | 8.28e-02 | 0.1617 |
7342 | UBP1 | P22T-E | Human | Esophagus | ESCC | 9.00e-15 | 1.48e-01 | 0.1236 |
7342 | UBP1 | P23T-E | Human | Esophagus | ESCC | 1.24e-09 | 1.47e-01 | 0.108 |
7342 | UBP1 | P24T-E | Human | Esophagus | ESCC | 9.01e-12 | 3.96e-02 | 0.1287 |
7342 | UBP1 | P26T-E | Human | Esophagus | ESCC | 5.43e-09 | 2.49e-02 | 0.1276 |
7342 | UBP1 | P27T-E | Human | Esophagus | ESCC | 4.67e-13 | 5.38e-02 | 0.1055 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000155826 | Thyroid | ATC | regulation of cell growth | 201/6293 | 414/18723 | 1.57e-10 | 4.76e-09 | 201 |
GO:004578614 | Thyroid | ATC | negative regulation of cell cycle | 181/6293 | 385/18723 | 2.64e-08 | 5.07e-07 | 181 |
GO:003288613 | Thyroid | ATC | regulation of microtubule-based process | 114/6293 | 240/18723 | 5.17e-06 | 5.59e-05 | 114 |
GO:001094813 | Thyroid | ATC | negative regulation of cell cycle process | 134/6293 | 294/18723 | 1.19e-05 | 1.15e-04 | 134 |
GO:006184216 | Thyroid | ATC | microtubule organizing center localization | 23/6293 | 33/18723 | 2.45e-05 | 2.14e-04 | 23 |
GO:003102311 | Thyroid | ATC | microtubule organizing center organization | 71/6293 | 143/18723 | 5.11e-05 | 3.99e-04 | 71 |
GO:005164215 | Thyroid | ATC | centrosome localization | 22/6293 | 32/18723 | 5.14e-05 | 3.99e-04 | 22 |
GO:000709811 | Thyroid | ATC | centrosome cycle | 65/6293 | 130/18723 | 7.95e-05 | 5.97e-04 | 65 |
GO:005507632 | Thyroid | ATC | transition metal ion homeostasis | 66/6293 | 138/18723 | 3.64e-04 | 2.25e-03 | 66 |
GO:0051494110 | Thyroid | ATC | negative regulation of cytoskeleton organization | 76/6293 | 163/18723 | 3.68e-04 | 2.27e-03 | 76 |
GO:007269711 | Thyroid | ATC | protein localization to cell cortex | 9/6293 | 11/18723 | 1.46e-03 | 7.47e-03 | 9 |
GO:005507214 | Thyroid | ATC | iron ion homeostasis | 41/6293 | 85/18723 | 3.62e-03 | 1.58e-02 | 41 |
GO:004660512 | Thyroid | ATC | regulation of centrosome cycle | 26/6293 | 49/18723 | 3.87e-03 | 1.68e-02 | 26 |
GO:00512981 | Thyroid | ATC | centrosome duplication | 36/6293 | 73/18723 | 3.91e-03 | 1.70e-02 | 36 |
GO:001082411 | Thyroid | ATC | regulation of centrosome duplication | 24/6293 | 45/18723 | 4.97e-03 | 2.03e-02 | 24 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
UBP1 | SNV | Missense_Mutation | c.1427N>T | p.Ser476Leu | p.S476L | Q9NZI7 | protein_coding | tolerated(0.75) | benign(0) | TCGA-BH-A0HK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | |
UBP1 | SNV | Missense_Mutation | c.645N>C | p.Gln215His | p.Q215H | Q9NZI7 | protein_coding | tolerated(0.45) | benign(0.062) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
UBP1 | insertion | Frame_Shift_Ins | novel | c.736_737insA | p.Thr246AsnfsTer2 | p.T246Nfs*2 | Q9NZI7 | protein_coding | TCGA-A8-A09N-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | ||
UBP1 | SNV | Missense_Mutation | novel | c.422G>A | p.Arg141His | p.R141H | Q9NZI7 | protein_coding | deleterious(0.03) | possibly_damaging(0.749) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
UBP1 | SNV | Missense_Mutation | novel | c.310G>A | p.Asp104Asn | p.D104N | Q9NZI7 | protein_coding | deleterious(0.05) | possibly_damaging(0.633) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
UBP1 | SNV | Missense_Mutation | c.471N>G | p.Ile157Met | p.I157M | Q9NZI7 | protein_coding | tolerated(0.07) | benign(0.411) | TCGA-A6-3809-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
UBP1 | SNV | Missense_Mutation | c.869N>G | p.Lys290Arg | p.K290R | Q9NZI7 | protein_coding | tolerated(0.21) | benign(0.007) | TCGA-AA-A022-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
UBP1 | SNV | Missense_Mutation | c.586N>T | p.Arg196Trp | p.R196W | Q9NZI7 | protein_coding | deleterious(0.03) | possibly_damaging(0.511) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
UBP1 | SNV | Missense_Mutation | c.1146N>A | p.Phe382Leu | p.F382L | Q9NZI7 | protein_coding | tolerated(0.08) | benign(0.253) | TCGA-CA-6718-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
UBP1 | SNV | Missense_Mutation | rs774635168 | c.535N>T | p.Arg179Cys | p.R179C | Q9NZI7 | protein_coding | deleterious(0.04) | benign(0.082) | TCGA-CM-4743-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Chemotherapy | capecitabine | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |